| 000 | 01043 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517223643.0 | ||
| 264 | 0 | _c20190415 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a0929-6646 | ||
| 024 | 7 |
_a10.1016/j.jfma.2018.05.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHsu, Chao-Wei | |
| 245 | 0 | 0 |
_aReply to "letter to the editor"-combination therapy for chronic hepatitis B: The future and beyond. _h[electronic resource] |
| 260 |
_bJournal of the Formosan Medical Association = Taiwan yi zhi _c08 2018 |
||
| 300 |
_a747-748 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAntiviral Agents |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aHepatitis B virus |
| 650 | 0 | 4 | _aHepatitis B, Chronic |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aChien, Rong-Nan | |
| 700 | 1 | _aLiaw, Yun-Fan | |
| 773 | 0 |
_tJournal of the Formosan Medical Association = Taiwan yi zhi _gvol. 117 _gno. 8 _gp. 747-748 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jfma.2018.05.022 _zAvailable from publisher's website |
| 999 |
_c28556848 _d28556848 |
||